Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process

被引:54
作者
Kempe, Sabine [1 ]
Metz, Hendrik [1 ]
Maeder, Karsten [1 ]
机构
[1] Univ Halle Wittenberg, Inst Pharm, Pharmaceut & Biopharmaceut Div, D-06120 Halle, Germany
关键词
Poly(lactide-co-glycolide); EPR; ESR; In situ forming implants; In vitro-in vivo correlation;
D O I
10.1016/j.jconrel.2008.06.006
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Electron paramagnetic resonance (EPR) spectroscopy was applied to monitor non-invasively the formation of in situ forming implants in vitro and in vivo after the administration of poly(lactide-co-glycolide) (PLGA)/N-methyl-pyrrolidone (NMP) solutions. The nitroxide spin probe 4-benzoyloxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TB) was incorporated in polymer solutions and samples were incubated in 0.1 M phosphate buffer (pH 7.4) at 37 degrees C or injected subcutaneously in the femoral of BALB/c mice. EPR permitted the direct and continuous determination of the NMP-water exchange during implant formation both in vitro and in living mice. The formation of the implant structure followed a two phase mechanism: over 75% of the polymer precipitated immediately after injection within the first 30 min and formed a solid shell. The subsequent moderate solidification of the implants was governed by diffusion and was completed after 24 h. The replacement of the organic solvent NMP by water was determined by polarity shifts within the implant and could be quantified. Both the kinetic of NIMP-water exchange and polymer precipitation showed good in vitro-in vivo correlation. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:220 / 225
页数:6
相关论文
共 32 条
[1]  
Atkins P. W., 1990, PHYS CHEM
[2]   Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds [J].
Balakrishnan, B ;
Jayakrishnan, A .
BIOMATERIALS, 2005, 26 (18) :3941-3951
[3]   Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration [J].
Besheer, A ;
Wood, KM ;
Peppas, NA ;
Mäder, K .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :73-80
[4]   Phase inversion dynamics of PLGA solutions related to drug delivery - Part II. The role of solution thermodynamics and bath-side mass transfer [J].
Brodbeck, KJ ;
DesNoyer, JR ;
McHugh, AJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 62 (03) :333-344
[5]   Sustained release of human growth hormone from PLGA solution depots [J].
Brodbeck, KJ ;
Pushpala, S ;
McHugh, AJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (12) :1825-1829
[6]   Smart hydrogels for in situ generated implants [J].
Cohn, D ;
Sosnik, A ;
Garty, S .
BIOMACROMOLECULES, 2005, 6 (03) :1168-1175
[7]   Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems [J].
Dong, W. Y. ;
Koerber, M. ;
Lopez Esguerra, V. ;
Bodmeier, R. .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (02) :158-167
[8]   Therapeutic applications of viscous and injectable poly(ortho esters) [J].
Einmahl, S ;
Capancioni, S ;
Schwach-Abdellaoui, K ;
Moeller, M ;
Behar-Cohen, F ;
Gurny, R .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 53 (01) :45-73
[9]   Polymer microspheres for controlled drug release [J].
Freiberg, S ;
Zhu, X .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 282 (1-2) :1-18
[10]   Phase inversion dynamics of PLGA solutions related to drug delivery [J].
Graham, PD ;
Brodbeck, KJ ;
McHugh, AJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 58 (02) :233-245